Browsing by Author Lee, Paul

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中
Showing results 5 to 12 of 12 < previous 
TitleAuthor(s)Issue Date
 
Efficacy and safety of ropeginterferon alfa-2b for pre-fibrotic primary myelofibrosis and dipss low/intermediate-1 risk myelofibrosis: updated results and genomic characteristics (oral presentation)
Proceeding/Conference:European Hematology Association Annual Congress 2023 (08/06/2023-15/06/2023, Frankfurt)
Singh, Gill Harinder HarryAu, Lester Siu ShanTsai, Yan YuLeung, Man Kit GarretYim, Rita Lok HayChin, Zan LynnLi, Wing Kan VivianLee, PaulSin, Chun FungHou, Hsin AnChen, Chih Cheng
10-Jun-2023
 
Molecular epidemiology of human coronavirus OC43 in Hong Kong
Lee, Paul李保羅
2007
 
Myelodysplastic syndrome in the omics era : from genomic prognostication to mechanisms of resistance
Lee, Paul李金瀚
2024
 
Oral-ato/atra/ascorbic acid (aaa)-based induction or maintenance of first complete remission improved outcomes in newly diagnosed apl: a multicentre analysis of the apl asian consortium (aplac) (poster presentation)
Proceeding/Conference:European Hematology Association Annual Congress 2023 (08/06/2023-15/06/2023, Frankfurt)
Singh, Gill Harinder HarryRaghupathy, RadhaHou, Hsin-AnTantiworawit, AdisakOoi, Melissa GChia, Priscella SGan, Gin GinWong, Chieh LeeChin, Zan LynnYim, Rita Lok HayLee, PaulAu, Lester Siu ShanLi, Wing Kan VivianLeung, Man Kit GarretChng, Wee JooChou, Wen ChienTien, Hwei-FangKumana, Cyrus RustamKwong, Yok Lam
9-Jun-2023
 
P493: ORAL-ATO/ATRA/ASCORBIC ACID (AAA)-BASED INDUCTION OR MAINTENANCE OF FIRST COMPLETE REMISSION IMPROVED OUTCOMES IN NEWLY DIAGNOSED APL: A MULTICENTRE ANALYSIS OF THE APL ASIAN CONSORTIUM (APLAC)
Journal:HemaSphere
Gill, HarryRaghupathy, RadhaHou, Hsin-AnTantiworawit, AdisakOoi, Melissa GChia, Priscella SGin, Gan GinWong, Chieh-LeeChin, LynnYim, RitaLee, PaulAu, LesterLI, VivianKit, Garret Leung ManJoo, Chng WeeChien, Chou WenTien, Hwei-FangKumana, CyrusLam, Kwong Yok
1-Aug-2023
 
Phase 2 Study to Assess the Safety and Efficacy of Bomedemstat (MK3543) in Combination with Ruxolitinib in Patients with Myelofibrosis
Journal:Blood
Singh, Gill HarinderAu, LesterTsai, DorothyYim, RitaChin, LynnLi, VivianLee, PaulLeung, Rock Yuk YanLee, ElaineRienhoff, Jr Hugh YoungKwong, Yok Lam
28-Nov-2023
 
Ropeginterferon Alfa-2b for Pre-Fibrotic Primary Myelofibrosis and DIPSS Low/Intermediate-1 Risk Myelofibrosis: Durable Responses and Evidence of Disease Modification
Journal:Blood
Gill, HarinderAu, LesterLeung, Garret Man KitTsai, DorothyYim, RitaChin, LynnLi, VivianLee, PaulSin, Albert Chun FungHou, Hsin AnChen, Chih-ChengKwong, Yok Lam
28-Nov-2023
 
S211: EFFICACY AND SAFETY OF ROPEGINTERFERON ALFA-2B FOR PRE-FIBROTIC PRIMARY MYELOFIBROSIS AND DIPSS LOW/INTERMEDIATE-1 RISK MYELOFIBROSIS: UPDATED RESULTS AND GENOMIC CHARACTERISTICS
Journal:HemaSphere
Gill, HarryAu, LesterTsai, DorothyLeung, Man Kit GarretYim, RitaChin, LynnLI, VivianLee, PaulSin, Chung Fung AlbertHou, Hsin-AnChen, Chih-ChengKwong, Yok Lam
1-Aug-2023
Showing results 5 to 12 of 12 < previous